PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA. dfrasca@med.miami.edu.\', \'Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA. dfrasca@med.miami.edu.\', \'Department of Pathology & Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.\', \'Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA.\', \'Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41366-021-01016-9
?:hasPublicationType
?:journal
  • International journal of obesity (2005)
is ?:pmid of
?:pmid
?:pmid
  • 34744161
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The majority of SARS-CoV-2-specific antibodies in COVID-19 patients with obesity are autoimmune and not neutralizing.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all